Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jellinger

Showing results (231-240 of 364) with videos related to

Pageof 37
Sort By:
Acta Neuropathologica|January 1, 1988
Reactivity of circulating antineuronal antibodies (CANA) on peripheral nervous system structuresW Grisold, M Drlicek, U Liszka, et al.
Journal of Neurology|January 1, 1979
The symptomatology with the most severe clinical course of spontaneous subarachnoid hemorrhageH Binder, F Gerstenbrand, K Jellinger, et al.
European Journal of Neurology|August 28, 2003
Guillain-Barré syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnosesH Rauschka, K Jellinger, H Lassmann, et al.
European Neurology|January 1, 1990
Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophreniaR K Pearce, P Seeman, K Jellinger, et al.
Acta Neuropathologica|July 21, 1999
The N-methyl-D-aspartate receptor channel blocker amantadine does not cause histopathological alterations in human brain tissueJ Kornhuber, K Jellinger, J Wiltfang, et al.
Acta Neuropathologica|August 7, 1978
Brain monoamines in human hepatic encephalopathyK Jellinger, P Riederer, G Kleinberger, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten|December 28, 1977
[Adult metachromatic leukodystrophy manifested as schizophrenic psychosis (author's transl)]P Kothbauer, K Jellinger, H Gross, et al.
Journal of Neural Transmission|January 1, 1982
Parkinson's disease putamen: normal concentration of synaptic membrane marker antigensO S Jørgensen, G P Reynolds, P Riederer, et al.
Journal of Neuropathology and Experimental Neurology|May 22, 1998
Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosisC Stadelmann, W Brück, C Bancher, et al.
Journal of the Neurological Sciences|December 1, 1973
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlationsH Bernheimer, W Birkmayer, O Hornykiewicz, et al.
Pageof 37

Showing results (231-240 of 364) with videos related to

Sort By:
Pageof 37
Acta Neuropathologica|January 1, 1988
Reactivity of circulating antineuronal antibodies (CANA) on peripheral nervous system structuresW Grisold, M Drlicek, U Liszka, et al.
Journal of Neurology|January 1, 1979
The symptomatology with the most severe clinical course of spontaneous subarachnoid hemorrhageH Binder, F Gerstenbrand, K Jellinger, et al.
European Journal of Neurology|August 28, 2003
Guillain-Barré syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnosesH Rauschka, K Jellinger, H Lassmann, et al.
European Neurology|January 1, 1990
Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophreniaR K Pearce, P Seeman, K Jellinger, et al.
Acta Neuropathologica|July 21, 1999
The N-methyl-D-aspartate receptor channel blocker amantadine does not cause histopathological alterations in human brain tissueJ Kornhuber, K Jellinger, J Wiltfang, et al.
Acta Neuropathologica|August 7, 1978
Brain monoamines in human hepatic encephalopathyK Jellinger, P Riederer, G Kleinberger, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten|December 28, 1977
[Adult metachromatic leukodystrophy manifested as schizophrenic psychosis (author's transl)]P Kothbauer, K Jellinger, H Gross, et al.
Journal of Neural Transmission|January 1, 1982
Parkinson's disease putamen: normal concentration of synaptic membrane marker antigensO S Jørgensen, G P Reynolds, P Riederer, et al.
Journal of Neuropathology and Experimental Neurology|May 22, 1998
Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosisC Stadelmann, W Brück, C Bancher, et al.
Journal of the Neurological Sciences|December 1, 1973
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlationsH Bernheimer, W Birkmayer, O Hornykiewicz, et al.
Pageof 37